Home

Medicamen Biotech Ltd EPS

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

EPS

₹ 6.61

Last updated on: Apr 09, 2025

Key Highlights

  • The Earning per Share of Medicamen Biotech Ltd is ₹ 6.61 as of 09 Apr 25 .
  • The earning per share of Medicamen Biotech Ltd changed from ₹ 3.12 to ₹ 2.3 over 7 quarters. This represents a CAGR of -15.99% .

Historical Earning per Share of Medicamen Biotech Ltd

No data available

* All values are in

Company Fundamentals for Medicamen Biotech Ltd

Market Cap

626 Cr

EPS

6.6

P/E Ratio (TTM)

74.6

P/B Ratio (TTM)

2.9

Day’s High

509.85

Day’s Low

470.65

DTE

0.1

ROE

3.4

52 Week High

630.0

52 Week Low

377.0

ROCE

5.8

Market Price of Medicamen Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Medicamen Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 Apr 2025492.85
08 Apr 2025492.5
07 Apr 2025460.7
04 Apr 2025500.8
03 Apr 2025527.4
02 Apr 2025485.2
01 Apr 2025494.55
28 Mar 2025481.7
27 Mar 2025455.9
26 Mar 2025440.3

SWOT Analysis Of Medicamen Biotech Ltd

Strength

4

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Medicamen Biotech Ltd

Asset Value vs Market Value of Medicamen Biotech Ltd

Market Value

627

Asset Value

Value addition

2.9 X

162

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Medicamen Biotech Ltd626.64
Sun Pharmaceutical Industries Ltd396394
Divis Laboratories Ltd142920
Cipla Ltd114383
Torrent Pharmaceuticals Ltd105812
Mankind Pharma Ltd95481

Historical Market Cap of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Medicamen Biotech Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Medicamen Biotech Ltd News Hub

Medicamen Biotech consolidated net profit declines 67.70% in the June 2024 quarter

Net profit of Medicamen Biotech declined 67.70% to Rs 1.35 crore in the quarter ended June 2024 as a

Read more

13 Aug 24

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024. Po

Read more

12 Aug 24

Medicamen Biotech to conduct AGM

Medicamen Biotech announced that the Annual General Meeting (AGM) of the company will be held on 26

Read more

13 Sept 24

Medicamen Biotech declare Quarterly Result

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024 P

Read more

08 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Medicamen Biotech Ltd

What is the EPS of Medicamen Biotech Ltd stock?

The Earnings Per Share (EPS) of Medicamen Biotech Ltd is 6.61. An EPS is the amount of net income attributed to each share of a common stock.

How is Medicamen Biotech Ltd EPS calculated?

The EPS of Medicamen Biotech Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Medicamen Biotech Ltd report its EPS?

Medicamen Biotech Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Medicamen Biotech Ltd EPS?

Factors that influence the EPS of Medicamen Biotech Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Medicamen Biotech Ltd EPS growth indicate future performance?

Yes, consistent growth in Medicamen Biotech Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions